Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulization of Alkaline Solution for XDRAB Pneumonia
NCT02060149Phase 2Unknown
- Sponsor
- Xijing Hospital
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sodium bicarbonate ringer's solution in pneumonia (3 arms), sponsored by Xijing Hospital. Primary endpoints: Pathogenic Clearance rate at 2 weeks and Recovery rate at 2 weeks. Status: unknown.
02
Drugs
sodium bicarbonate ringer's solution
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT02060149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060149.